Q4 2025 earnings call recap: sales growth, margin outlook, 2026 guidance, buybacks & dividend hike, plus key wins—read now.

C Energy has completed laboratory validation of its proprietary geothermal reservoir stimulation technology in superhot ...

TransCon Growth Hormone or TransCon hGH is now approved in the US by the FDA for the replacement of endogenous growth hormone ...

Q4 2025 Earnings Call February 10, 2026 4:30 PM ESTCompany ParticipantsJacquie Ross - Senior Vice President of Treasury ...

International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) today released its financial and operating results and related management’s discussion and analysis (MD&A) ...

Updated PEA Copper Fox has commissioned Moose Mountain Technical Services to prepare an updated PEA on the Van Dyke copper project in accordance with the Canadian disclosure requirements of National ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has completed the previously disclosed spin-off of its Biosciences & Diagnostic business, followed by the merger of ...

Proto Labs, Inc. (NYSE:PRLB) Q4 2025 Earnings Call Transcript February 6, 2026 Proto Labs, Inc. beats earnings expectations.

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.

Citizenship requirements taking effect March 1 will block millions of would-be entrepreneurs from accessing affordable capital.

Looking to navigate the AI startup space? Start by focusing on defensible technology and regulatory foundations, rather than simply building interfaces on existing platforms, say experts at a recent ...